Literature DB >> 23532502

Follicular epithelial dysplasia of the thyroid: morphological and immunohistochemical characterization of a putative preneoplastic lesion to papillary thyroid carcinoma in chronic lymphocytic thyroiditis.

Michael Herman Chui1, Clarissa A Cassol, Sylvia L Asa, Ozgur Mete.   

Abstract

In chronic lymphocytic thyroiditis (CLT), the follicular epithelial cells display cytological atypia resembling papillary thyroid carcinoma (PTC), and epidemiological studies have suggested an increased risk of PTC in patients with this condition. While reactive atypia is observed diffusely in CLT-affected thyroid parenchyma, it is not unusual to find microscopic foci morphologically distinct from the surrounding parenchyma, exhibiting more pronounced cytological and architectural atypia. These small atypical lesions, which we term "follicular epithelial dysplasia" (FED), are particularly prominent in cases of severe CLT, yet lack invasive growth, papillary architecture, or intranuclear pseudoinclusions. To gain further insight into their biological significance, we constructed a tissue microarray of 70 cases of CLT, comprised of morphologically normal thyroid, thyroid with reactive atypia, FED, follicular nodular disease (nodular hyperplasia or follicular adenoma), and PTC. Immunohistochemical staining was performed for a marker panel including PTC (HBME-1, cytokeratin 19, galectin-3, and cyclin-D1) as well as TTF-1, thyroglobulin, and p63. Slides were digitally scanned and immunohistochemical staining evaluated using automated image analysis software. FED lesions were positive for TTF-1 and thyroglobulin (50/50, 100 %), though some (13/50, 26 %) also expressed p63. Similar to PTC, strong diffuse staining was observed for HBME-1 (43/50, 86 %), cytokeratin 19 (48/50, 96 %), galectin-3 (20/50, 40 %) and cyclin-D1 (38/50, 76 %). In contrast, normal thyroid, reactive atypia, and follicular nodular disease were negative, or at most, exhibited focal weak staining for HBME-1, cytokeratin 19, and galectin-3. The results of this study demonstrate the presence of atypical microscopic lesions in CLT with an immunohistochemical profile similar to PTC, supporting the concept of a premalignant lesion preceding PTC, arising in the context of severe chronic inflammation.

Entities:  

Mesh:

Year:  2013        PMID: 23532502     DOI: 10.1007/s00428-013-1397-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells.

Authors:  M N Nikiforova; J R Stringer; R Blough; M Medvedovic; J A Fagin; Y E Nikiforov
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas.

Authors:  Marina N Nikiforova; Christy M Caudill; Paul Biddinger; Yuri E Nikiforov
Journal:  Int J Surg Pathol       Date:  2002-01       Impact factor: 1.271

3.  Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis.

Authors:  Jennifer L Hunt; Zubair W Baloch; Leon Barnes; Patricia A Swalsky; Cindy L Trusky; E Sesatomi; Sydney Finkelstein; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 4.  Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

Review 5.  Morphogenetics of early thyroid development.

Authors:  Henrik Fagman; Mikael Nilsson
Journal:  J Mol Endocrinol       Date:  2011-02       Impact factor: 5.098

6.  Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.

Authors:  Peter M Sadow; Michael C Heinrich; Christopher L Corless; Jonathan A Fletcher; Vânia Nosé
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Hashimoto thyroiditis coexistent with papillary thyroid carcinoma.

Authors:  Calogero Cipolla; Luigi Sandonato; Giuseppa Graceffa; Salvatore Fricano; Adriana Torcivia; Salvatore Vieni; Stefania Latteri; Mario Adelfio Latteri
Journal:  Am Surg       Date:  2005-10       Impact factor: 0.688

9.  Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans.

Authors:  I Okayasu; M Fujiwara; Y Hara; Y Tanaka; N R Rose
Journal:  Cancer       Date:  1995-12-01       Impact factor: 6.860

Review 10.  Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia.

Authors:  George L Mutter; Richard J Zaino; Jan P A Baak; Rex C Bentley; Stanley J Robboy
Journal:  Int J Gynecol Pathol       Date:  2007-04       Impact factor: 2.762

View more
  13 in total

1.  Emerin expression in well differentiated epithelial lesions of thyroid: implications in papillary thyroid carcinoma diagnosis and predicting malignant behavior.

Authors:  Ipek Coban; Asli Cakir; Tuba Dilay Kokenek Unal; Nuray Bassullu; Vildan Karpuz; Gulen Bulbul Dogusoy; Murat Alper
Journal:  Pathol Oncol Res       Date:  2014-08-14       Impact factor: 3.201

2.  The Value of HBME-1 and Claudin-1 Expression Profile in the Distinction of BRAF-Like and RAS-Like Phenotypes in Papillary Thyroid Carcinoma.

Authors:  Hasan Gucer; Pelin Bagci; Recep Bedir; Ibrahim Sehitoglu; Ozgur Mete
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

3.  Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis.

Authors:  Xiao-Xiong Gan; Ya-Yi Li; Si-Jin Li; Shi-Sen Mo; Jian-Hua Feng; Fei Shen; Wen-Song Cai; Ye-Qian Lai; Bo Xu
Journal:  Front Oncol       Date:  2021-08-04       Impact factor: 6.244

4.  Incidentally discovered papillary thyroid microcarcinoma in patients undergoing thyroid surgery for benign disease.

Authors:  Joaquín de Carlos; Ander Ernaga; Ana Irigaray; Jose Javier Pineda; Ana Echegoyen; Pilar Salvador; Emma Anda
Journal:  Endocrine       Date:  2022-05-31       Impact factor: 3.925

5.  Squamous Differentiation in the Thyroid: Metaplasia, Neoplasia, or Bystander?

Authors:  Meagan A Chambers; Peter M Sadow; Darcy A Kerr
Journal:  Int J Surg Pathol       Date:  2021-12-13       Impact factor: 1.358

Review 6.  The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma.

Authors:  Roberto Vita; Antonio Ieni; Giovanni Tuccari; Salvatore Benvenga
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 7.  Immune response in thyroid cancer: widening the boundaries.

Authors:  Laura Sterian Ward
Journal:  Scientifica (Cairo)       Date:  2014-09-25

8.  Mutation of Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma Related Genes and the Screening of Candidate Genes.

Authors:  Lizhuo Zhang; Lingyan Zhou; Qingqing Feng; Qinglin Li; Minghua Ge
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

9.  Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients.

Authors:  Yoon Young Cho; Yun Jae Chung; Hee Sung Kim
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

10.  Follicular Epithelial Dysplasia as Hashimoto Thyroiditis-Related Atypia: a Series of 91 Specimens.

Authors:  Ivana Kholová; David Kalfert; Jarkko Lintusaari; Erja Rajakorpi; Marie Ludvíková
Journal:  Endocr Pathol       Date:  2021-05-15       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.